- One Medical is set to start trading Friday after pricing its shares at $14 on Thursday night, raising $245 million.
- The company trades under the ticker “ONEM.”
- One Medical operates primary-care practices that charge a $200 annual fee and also bills your health insurance.
- Visit Business Insider’s homepage for more stories.
Primary care company One Medical is set to start trading on Friday.
On Thursday, One Medical priced its shares at $14 apiece, the low end of its expected range of $14-$16 a share.
One Medical sold 17.5 million shares, raising $245 million in the offering.
Read more: Here are the investors and execs at One Medical who stand to make the most in the IPO
Courtesy One Medical
One Medical’s approach to primary care
One Medical was founded by Tom Lee, who served as the company’s CEO until 2017. Current CEO Amir Rubin
joined One Medical in 2017 after working as an executive at UnitedHealth Group’s Optum division. Before that, he was the CEO of Stanford Health Care.
Lee, for his part, has founded a new healthcare startup called Galileo, which offers a mix of online and in-person care. The aim is to do a better job of taking care of sicker people in the government-funded healthcare programs Medicare and Medicaid.
Never miss out on healthcare news. Subscribe to Dispensed, our weekly newsletter on pharma, biotech, and healthcare.
When One Medical opened for business in San Francisco in 2007, its goal was to upend the way people got medical care by making it easy and convenient to see a doctor. The company charges a $200 annual fee and bills your insurance. One Medical had 397,000 members and operated in 77 locations as of September 30, the filing says.
The company’s net losses deepened as membership climbed, the filing shows. From 2017 to 2018, losses widened from $31.7 million to $44.4 million. For the first nine months of 2019, One Medical’s net loss was $34.2 million.
One Medical’s top investors going into the IPO include The Carlyle Group, which owns 26.8%, Benchmark Capital, which owns 13%, Oak Investment Partners, Lee, DAG Ventures, GV, JPMorgan, and Maverick Fund.
JPMorgan Chase and Morgan Stanley led the IPO.
Leave a Reply
Leave a Reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
